Results 261 to 270 of about 72,115 (280)

Nonclassic adrenal hyperplasia

Reviews in Endocrine and Metabolic Disorders, 2008
Nonclassic adrenal hyperplasia is most commonly attributable to mutations in CYP21A2 (also termed CYP21) encoding steroid 21-hydroxylase. Partial deficiency of this enzyme causes an imbalance in cortisol synthesis with consequent adrenal androgen excess.
openaire   +2 more sources

Adrenal Medullary Hyperplasia: Hyperplasia‐pheochromocytoma Sequence

Acta Pathologica Japonica, 1990
We present a case of unilateral adrenal medullary hyperplasia in a 63‐year‐old woman with‐clinical signs and symptoms of pheochromocytoma unassociated with multiple endocrine neoplasia. The surgically removed adrenal gland revealed diffuse medullary hyperplasia with multiple micronodules measuring up to 2 mm.
K, Kurihara, K, Mizuseki, T, Kondo, H, Ohoka, M, Mannami, K, Kawai   +5 more
openaire   +2 more sources

Congenital Adrenal Hyperplasia

2019
Congenital adrenal hyperplasia (CAH) is a group of seven autosomal recessively inherited disorders of various enzymes participating in adrenal steroid hormone synthesis. Patients present with various symptoms depending on the nature and severity of the enzymatic block. More than 95% of all CAH patients suffer from 21-hydroxylase deficiency. The genetic
openaire   +2 more sources

Congenital Adrenal Hyperplasias

Endocrinology and Metabolism Clinics of North America, 1991
The congenital adrenal hyperplasias (CAH) are a very common group of genetic disorders of steroid hormone synthesis. The genes encoding each of the steroid biosynthetic enzymes have now been cloned, and the mutations in these genes that cause the various forms of CAH are being determined. The emerging picture is substantially different from traditional
openaire   +2 more sources

Congenital adrenal hyperplasias

Best Practice & Research Clinical Endocrinology & Metabolism, 2001
Congenital adrenal hyperplasia syndromes result from deficiencies of enzymes involved in corticosteroid biosynthesis. Most commonly, they are due to mutations in 21-hydroxylase. This chapter describes the clinical diagnosis and management of congenital adrenal hyperplasias throughout life, including in the fetus, child and adult.
openaire   +2 more sources

Congenital adrenal hyperplasia

Clinics in Endocrinology and Metabolism, 1985
Congenital adrenal hyperplasia (CAB) is an inherited disorder of adrenal steroid biosynthesis. The basic defect is the deficiency of an enzyme in the pathway of cortisol production. This results in distinct biochemical and clinical features, each depending on the site of the deficient enzyme, and on the secondary effects of steroids, which are produced
openaire   +2 more sources

Nonclassic congenital adrenal hyperplasia

Current Opinion in Endocrinology, Diabetes & Obesity, 2012
Late-onset or nonclassic congenital adrenal hyperplasia (NCAH) due to 21-hydroxylase deficiency is one of the most common autosomal recessive disorders. Reported prevalence ranges from 1 in 30 to 1 in 1000. Affected individuals typically present due to signs and symptoms of androgen excess.
openaire   +3 more sources

Congenital Virilizing Adrenal Hyperplasia

Archives of Pediatrics & Adolescent Medicine, 1960
In the past several years, great strides have been made in the elucidation of certain inborn defects in steroid metabolism. This has led to a better understanding of the pathophysiology of congenital virilizing adrenal hyperplasia and has given us a more rational approach to the treatment of this disorder.
openaire   +2 more sources

Virilizing Adrenal Hyperplasia

Southern Medical Journal, 1959
H A, BURKE, G W, LIDDLE
openaire   +2 more sources

Congenital Adrenal Hyperplasia

Biochemical Society Transactions, 1968
openaire   +3 more sources